These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
231 related items for PubMed ID: 11162046
1. Clinical applications of magnetic drug targeting. Lübbe AS, Alexiou C, Bergemann C. J Surg Res; 2001 Feb; 95(2):200-6. PubMed ID: 11162046 [Abstract] [Full Text] [Related]
2. Magnetic drug targeting--biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment. Alexiou C, Jurgons R, Schmid RJ, Bergemann C, Henke J, Erhardt W, Huenges E, Parak F. J Drug Target; 2003 Apr; 11(3):139-49. PubMed ID: 13129824 [Abstract] [Full Text] [Related]
3. Preclinical experiences with magnetic drug targeting: tolerance and efficacy. Lübbe AS, Bergemann C, Huhnt W, Fricke T, Riess H, Brock JW, Huhn D. Cancer Res; 1996 Oct 15; 56(20):4694-701. PubMed ID: 8840986 [Abstract] [Full Text] [Related]
6. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Maeda H, Bharate GY, Daruwalla J. Eur J Pharm Biopharm; 2009 Mar 15; 71(3):409-19. PubMed ID: 19070661 [Abstract] [Full Text] [Related]
7. Role of nanocarrier systems in cancer nanotherapy. Mozafari MR, Pardakhty A, Azarmi S, Jazayeri JA, Nokhodchi A, Omri A. J Liposome Res; 2009 Mar 15; 19(4):310-21. PubMed ID: 19863166 [Abstract] [Full Text] [Related]
11. Application of nanosized Fe3O4 in anticancer drug carriers with target-orientation and sustained-release properties. Lin BL, Shen XD, Cui S. Biomed Mater; 2007 Jun 15; 2(2):132-4. PubMed ID: 18458446 [Abstract] [Full Text] [Related]